Boston Scientific (BSX) Restructuring Costs (2009 - 2026)

Boston Scientific has disclosed Restructuring Costs across 18 years of filings, most recently posting $76.0 million for Q2 2026.

• In Q2 2026, Restructuring Costs fell 8.43% year-over-year to $76.0 million; the TTM figure through Jun 2026 stood at $180.0 million (up 71.43% YoY), while the FY2025 annual figure was $194.0 million, up 1112.5% from the prior year.
• Restructuring Costs came in at $76.0 million for Q2 2026 at Boston Scientific, up from $3.0 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $131.0 million in Q4 2022 to a low of -$111.0 million in Q3 2023.
• Average Restructuring Costs over 5 years is $23.2 million, with a median of $8.0 million recorded in 2024.
• Year-over-year, Restructuring Costs slumped 2875.0% in 2023 and soared 8200.0% in 2025.
• Over 5 years, Restructuring Costs stood at $131.0 million in 2022, then sank by 184.73% to -$111.0 million in 2023, then soared by 103.6% to $4.0 million in 2024, then surged by 2625.0% to $109.0 million in 2025, then sank by 30.28% to $76.0 million in 2026.
• Per Business Quant data, the three most recent Restructuring Costs figures were $76.0 million in Q2 2026, $3.0 million in Q1 2026, and $109.0 million in Q4 2025.